DIGITAL THERAPEUTICS

What are Prescription Digital Therapeutics?

Digital Therapeutics (DTx) are evidence-based, clinically-proven therapeutic interventions that incorporate software and devices to prevent, manage, or treat a medical disorder or disease.

Digital Therapeutics help physicians provide better quality of care for more patients in less time.

Digital Therapeutic technologies help address gaps in existing patient care, help reach underserved and at-risk patient populations, contribute to a better understanding of disease states and treatments, and streamline patient care and support.

Digital Therapeutics are technology solutions that are prescribed by physicians, and may be reimbursed through insurance payors.

“The launch of the Digital Health Center of Excellence is an important step in furthering the agency’s overarching dedication to the advancement of digital health technology, including mobile health devices, Software as a Medical Device (SaMD), wearables when used as a medical device, and technologies used to study medical products.”

— September 22, 2020, the U.S. Food and Drug Administration

Digital Therapeutics are quickly transforming treatment and management of a wide variety of chronic medical conditions, including Asthma, Cancer, Diabetes, Obesity, ADHD, Anxiety and Depression, Migraines, Pain – and now with Eyethena – Glaucoma.

Eyethena is the first-of-its kind Digital Therapeutics Technology for Glaucoma.